Mineralocorticoid Receptor in the Treatment of Severe Depression

NCT00295347 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

65

Enrollment

OTHER

Sponsor class

Conditions

Major Depression

Interventions

DRUG: Spironolactone
DRUG: fludrocortisone
DRUG: escitalopram

Sponsor

Universitätsklinikum Hamburg-Eppendorf